#asia 2026-06-25

diabetes indication only

no letter no charge

the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you received

a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic, ask me again in a month

insurance in the region tracked the diabetes indication in every country a member reported on

Testing queue: 3 submissions open, 16 awaiting dispatch.

japanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago, ask me again in a month
thailand and taiwan come up occasionally and we have almost no member reports from either, so i would not guess

summer shipping matters here too. i avoid july and august the way australian members avoid january

japan approved it for both indications a while ago as i understood it, and the approval did not make it cheap

language with a local pharmacy went better once i brought the compound name written down. spoken, it never worked once, from memory

lot number first

Testing queue: 2 submissions open, 32 awaiting dispatch.

hong kong, is it pharmacy or clinic in practice